Summary Response Assessment in Neuro-Oncology (RANO) response criteria have been
established and were updated in 2023 for MRI-based response evaluation of diffuse …

Fluorescence imaging is one of the most promising approaches to achieve intraoperative
assessment of the tumor/normal tissue margins during cancer surgery. This is critical to …

Activatable dual‐modal molecular imaging probes present a promising tool for the diagnosis
of malignant tumors. However, synchronously enhancing dual‐modal imaging signals under …

The liver is essential for metabolic homeostasis. The onset of liver cancer is often
accompanied by dysregulated liver function, leading to metabolic rearrangements …

Multimodal biomedical imaging and imaging‐guided therapy have garnered extensive
attention owing to the aid of nanoagents with the aim of further improving the therapeutic …

COST Action CA17140 Cancer Nanomedicine—from the bench to the bedside
(Nano2Clinic,) is the first, pan-European interdisciplinary network of representatives from …

Radiopharmaceuticals play a critical role in nuclear medicine, providing novel tools for
specifically delivering radioisotopes for the diagnosis and treatment of cancers. As the …

Signal-regulatory protein α (SIRPα) expressed by myeloid cells is of particular interest for
therapeutic strategies targeting the interaction between SIRPα and the “don't eat me” ligand …

Cancer treatment requires precise tumor‐specific targeting at specific sites that allows for
high‐resolution diagnostic imaging and long‐term patient‐tailorable cancer therapy; while …

Purpose Chimeric antigen receptor (CAR) T cell therapy has achieved great success in
treating hematologic malignancies. However, it is yet to prove effective in the treatment of …